Abstract:Despite the relationship between miRNAs and the carcinogenesis of colorectal cancer (CRC) have been extensively studied, the role of miR-452-5p in CRC remained elusive. Hence this study was designed to investigate the clinico-pathological value of miR-452-5p in CRC as well as to explore the molecular basis of miR-452-5p in CRC. The clinico-pathological significance of miR-452-5p in CRC was examined from the data in The Cancer Genome Atlas (TCGA) database. Meta-analysis for GSE datasets from gene expression omnibus (GEO) and an integrated meta-analysis with all the included GSE datasets and TCGA data were conducted to evaluate the expression level of miR-452-5p in CRC. Prognostic value of miR-452-5p in CRC was further examined by the survival curves from Progmir. We then predicted the target genes of miR-452-5p through miRWalk v 2.0. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted for the functional annotation of the target genes. After the determination of target genes, immunostaining results from the Human protein atlas (HPA) database were used to compare cyclin-dependent kinase inhibitor 1B (CDKN1B) expression in CRC and non-cancer tissues. Eventually, the target-ship between miR-452-5p and CDKN1B was identified through dual-luciferase reporter assay. Results from TCGA data mining, GEO meta-analysis and the integrated meta-analysis revealed that miR452-5p was overexpressed in CRC and was associated with the progression of CRC. Prognostic data from Progmir reported no obvious difference between the survival time of CRC patients with different expression of miR-452-5p. A total of 1156 genes were predicted as the potential target genes of miR-452-5p. GO and KEGG analysis for the potential target genes revealed that these genes were mainly enriched in the following biological process terms and pathway terms: sensory perception of sound, negative regulation of transcription, DNA-templated and positive regulation of cell cycle, pathways in cancer, transcriptional misregulation in cancer and chronic myeloid leukemia. Data from HPA supported the down-regulation of CDKN1B in CRC. Furthermore, the dual-luciferase reporter assay demonstrated that CDKN1B was directly targeted by miR-452-5p. In summary, the overexpressed of miR-452-5p may played an oncogenic role in CRC via targeting CDKN1B.

MiR-452-5 p may serve as an oncogene in colorectal cancer through targeting CDKN 1 B : a study based on bioinformatics analysis and dual-luciferase reporter assay

MiR-452 Promotes an Aggressive Colorectal Cancer Phenotype by Regulating a Wnt/β-catenin Positive Feedback Loop

Clinical Significance of High Expression of Mir-452-5p in Lung Squamous Cell Carcinoma.

MicroRNA-452 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting Cyclin-Dependent Kinase Inhibitor 1B.

Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases

Expression Level and Potential Target Pathways of Mir-1-3p in Colorectal Carcinoma Based on 645ï¿½cases from 9 Microarray Datasets

Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression

Prognostic value and potential regulatory relationship of miR‐200c‐5p in colorectal cancer

miR-500a-3p/CDK6 Axis Suppresses Aerobic Glycolysis in Colorectal Cancer

Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.

Identification Of The Potential Targets Of Mir-143-3p In Colorectal Cancer Through Bioinformatics Analysis

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

DNA-methylation-mediated Silencing of Mir-486-5p Promotes Colorectal Cancer Proliferation and Migration Through Activation of PLAGL2/IGF2/β-catenin Signal Pathways

MicroRNA 452 regulates SHC1 expression in human colorectal cancer and colitis

MicroRNA-455 Inhibits Proliferation and Invasion of Colorectal Cancer by Targeting RAF Proto-Oncogene Serine/threonine-Protein Kinase

Circular RNA (circ)_0053277 Contributes to Colorectal Cancer Cell Growth, Angiogenesis, Metastasis and Glycolysis

MicroRNA-455-3p Accelerate Malignant Progression of Tumor by Targeting H2AFZ in Colorectal Cancer

The Protective Value of Mir-204-5p for Prognosis and Its Potential Gene Network in Various Malignancies: a Comprehensive Exploration Based on RNA-seq High-Throughput Data and Bioinformatics.

miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.

Mir-378A-5p Inhibits the Proliferation of Colorectal Cancer Cells by Downregulating CDK1

Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B.